PACT Pharma has let go of 94 employees, leaving remaining staff to work on two clinical stage assets in immuno-oncology

PACT Pharma has let go of 94 employees, leaving remaining staff to work on two clinical stage assets in immuno-oncology, according to a state workforce report in California.

Launched in 2017 by a team that included Nobel Prize-winner David Baltimore, PACT emerged with the promise of developing personalized cancer therapies. Based on research from Antoni Ribas, a professor of medicine at UCLA’s Jonsson Comprehensive Cancer Center, the company most recently raised $75 million in an oversubscribed series C in January 2020. 

Source: https://bit.ly/3J6Qbf3